MACROGENICS, INC. Depreciation
MACROGENICS, INC. (MGNX) reported Depreciation of $7.20 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-09.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-03-09
- MACROGENICS, INC. depreciation for the quarter ending 2020-12-31 was $2.93M, a 4.21% decline year-over-year.
- MACROGENICS, INC. depreciation for the quarter ending 2020-09-30 was $2.96M, a 3.11% decline year-over-year.
- MACROGENICS, INC. depreciation for the quarter ending 2019-12-31 was $3.06M.
- MACROGENICS, INC. depreciation for the quarter ending 2019-09-30 was $3.06M.
- MACROGENICS, INC. depreciation for fiscal 2025 was $7.20M, a 4.00% decline from fiscal 2024.
- MACROGENICS, INC. depreciation for fiscal 2024 was $7.50M, a 21.88% decline from fiscal 2023.
- MACROGENICS, INC. depreciation for fiscal 2023 was $9.60M, a 19.33% decline from fiscal 2022.
- MACROGENICS, INC. depreciation for fiscal 2022 was $11.90M, a 5.31% increase from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 3 month as first filed | Depreciation 6 month | Depreciation 9 month | Depreciation 9 month as first filed | Depreciation 12 month | Depreciation 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | $7.20M 10-K · filed 2026-03-09 | ||||||
| 2024-12-31 | $7.50M 10-K · filed 2026-03-09 | ||||||
| 2023-12-31 | $9.60M 10-K · filed 2026-03-09 | ||||||
| 2022-12-31 | $11.90M 10-K · filed 2025-03-20 | ||||||
| 2021-12-31 | $11.30M 10-K · filed 2024-03-07 | ||||||
| 2020-12-31 | $2.93M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $5.89M derived: sum of 2 quarters · filed 2023-03-15 | $12.00M 10-K · filed 2023-03-15 | ||||
| 2020-09-30 | $2.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | $9.07M 10-Q · filed 2020-11-04 | |||||
| 2020-06-30 | $6.11M 10-Q · filed 2020-07-31 | ||||||
| 2019-12-31 | $3.06M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $6.12M derived: sum of 2 quarters · filed 2022-02-24 | $12.30M 10-K · filed 2022-02-24 | ||||
| 2019-09-30 | $3.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | $9.24M 10-Q · filed 2020-11-04 | |||||
| 2019-06-30 | $6.18M 10-Q · filed 2020-07-31 | ||||||
| 2018-12-31 | $9.20M 10-K · filed 2021-02-25 | ||||||
| 2017-12-31 | $7.00M 10-K · filed 2020-02-25 | ||||||
| 2016-12-31 | $1.17M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $3.24M derived: sum of 2 quarters · filed 2019-02-26 | $5.03M derived: sum of 3 quarters · filed 2019-02-26 | $6.80M 10-K · filed 2019-02-26 | |||
| 2016-09-30 | $2.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | $3.86M derived: sum of 2 quarters · filed 2016-11-02 | $5.63M 10-Q · filed 2016-11-02 | $7.16M derived: sum of 4 quarters · filed 2018-02-27 | |||
| 2016-06-30 | $1.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | $3.56M 10-Q · filed 2016-08-03 | $5.09M derived: sum of 3 quarters · filed 2018-02-27 | $5.58M derived: sum of 4 quarters · filed 2018-02-27 | |||
| 2016-03-31 | $1.77M 10-Q · filed 2016-05-04 | $3.30M derived: sum of 2 quarters · filed 2018-02-27 | $3.79M derived: sum of 3 quarters · filed 2018-02-27 | $4.42M derived: sum of 4 quarters · filed 2018-02-27 | |||
| 2015-12-31 | $1.53M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $2.02M derived: sum of 2 quarters · filed 2018-02-27 | $2.65M derived: sum of 3 quarters · filed 2018-02-27 | $3.20M 10-K · filed 2018-02-27 | $2.86M 10-K · filed 2016-02-29 | ||
| 2015-09-30 | $489.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | $1.13M derived: sum of 2 quarters · filed 2016-11-02 | $1.67M 10-Q · filed 2016-11-02 | $2.15M derived: sum of 4 quarters · filed 2017-02-28 | |||
| 2015-06-30 | $636.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | $1.18M 10-Q · filed 2016-08-03 | $1.67M derived: sum of 3 quarters · filed 2017-02-28 | $2.15M derived: sum of 4 quarters · filed 2017-02-28 | |||
| 2015-03-31 | $546.00K 10-Q · filed 2016-05-04 | $1.03M derived: sum of 2 quarters · filed 2017-02-28 | $1.51M derived: sum of 3 quarters · filed 2017-02-28 | $1.95M derived: sum of 4 quarters · filed 2017-02-28 | |||
| 2014-12-31 | $483.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $965.00K derived: sum of 2 quarters · filed 2017-02-28 | $1.40M derived: sum of 3 quarters · filed 2017-02-28 | $1.80M 10-K · filed 2017-02-28 | $1.82M 10-K · filed 2015-03-03 | ||
| 2014-09-30 | $482.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $919.00K derived: sum of 2 quarters · filed 2015-11-04 | $1.32M 10-Q · filed 2015-11-04 | $1.68M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-06-30 | $437.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | $835.00K 10-Q · filed 2015-08-05 | $1.19M derived: sum of 3 quarters · filed 2016-02-29 | $1.51M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-03-31 | $398.00K 10-Q · filed 2015-05-06 | $398.22K 10-Q · filed 2014-05-06 | $756.00K derived: sum of 2 quarters · filed 2016-02-29 | $1.07M derived: sum of 3 quarters · filed 2016-02-29 | $1.34M derived: sum of 4 quarters · filed 2016-02-29 | ||
| 2013-12-31 | $358.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $675.00K derived: sum of 2 quarters · filed 2016-02-29 | $940.82K derived: sum of 3 quarters · filed 2016-02-29 | $1.19M 10-K · filed 2016-02-29 | $1.19M 10-K · filed 2014-03-20 | ||
| 2013-09-30 | $317.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | $582.82K derived: sum of 2 quarters · filed 2014-11-12 | $835.00K 10-Q · filed 2014-11-12 | $834.62K 10-Q · filed 2013-11-12 | $1.07M derived: sum of 4 quarters · filed 2015-03-03 | ||
| 2013-06-30 | $265.81K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | $518.00K 10-Q · filed 2014-08-05 | $755.50K derived: sum of 3 quarters · filed 2015-03-03 | ||||
| 2013-03-31 | $252.19K 10-Q · filed 2014-05-06 | $489.69K derived: sum of 2 quarters · filed 2015-03-03 | |||||
| 2012-12-31 | $237.50K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-03 | $960.00K 10-K · filed 2015-03-03 | $959.93K 10-K · filed 2014-03-20 | ||||
| 2012-09-30 | $722.50K 10-Q · filed 2013-11-12 | ||||||
| 2011-12-31 | $1.15M 10-K · filed 2014-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |